This study assesses the potential of cladocerans as competitors for controlling the oviposition and larval abundances of mosquitoes. Control of mosquito larvae involving the use of antagonists has focused mostly on predators. We hypothesized that cladoceran competitors have a strong potential to control larval populations of some species of mosquitoes that can be early colonizers of newly-filled waterbodies, and should be less efficient competitors. To test this hypothesis, the establishment and development of larval populations of wild Culex pipiens were investigated in outdoor microcosms varying in terms of Daphnia magna populations. When the population was well established (i.e., high densities of D. magna), oviposition was fully inhibited and there was consequently no mosquito larvae. When the population was more recently established (i.e., lower densities of D. magna), oviposition and larval development of Cx. pipiens occurred. In the absence of D. magna, oviposition, larval biomass, and abundance of Cx. pipiens reached high values. In this situation, conspecifics were inhibiting further oviposition of Cx. pipiens. Based on these results, we suggest that competing Zooplankton species, such as D. magna, could be used for the control of mosquito species such as Cx. pipiens. This approach could be beneficial for the management of wetlands.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.